ArticleSchizophrenia bulletin2025

Commentary on "Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia (CIAS) and Other Neuropsychiatric Conditions: Insights from Two Decades of Clinical Trials".

Thomas P LaughrenPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.